Cargando…
Catheter‐based renal denervation in Chinese patients with chronic kidney disease and uncontrolled hypertension
Sympathetic activation contributes to the progression of hypertension and chronic kidney disease (CKD). Ablation of renal sympathetic nerves lowers blood pressure (BP) and preserves renal function in patients with CKD and uncontrolled hypertension by reducing sympathetic nerve activity. But whether...
Autores principales: | Liu, Senyan, Bian, Rongrong, Qian, Yixin, Liao, Huaqiang, Gao, Xiang, Zhang, Yuqiang, Dong, Weihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832231/ https://www.ncbi.nlm.nih.gov/pubmed/36478498 http://dx.doi.org/10.1111/jch.14605 |
Ejemplares similares
-
Lessons Learned from RADIOSOUND-HTN: Different Technologies and Techniques for Catheter-based Renal Denervation and Their Effect on Blood Pressure
por: Lurz, Philipp, et al.
Publicado: (2019) -
Kidney function and markers of renal damage after renal denervation. Does method of measurement matter? The Reshape CV‐Risk Study
por: Solbu, Marit D., et al.
Publicado: (2021) -
Thirty‐six‐month results of laparoscopic‐based renal denervation plus unilateral laparoscopic adrenalectomy for the treatment of patients with resistant hypertension caused by unilateral aldosterone‐producing adenoma
por: Liu, Yahui, et al.
Publicado: (2021) -
A Japan nationwide web‐based survey of estimation on patients for renal denervation based on blood pressure level and the number of antihypertensives (J‐NEEDs survey)
por: Kagitani, Hideaki, et al.
Publicado: (2021) -
Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study – a randomized controlled trial
por: Oliveras, Anna, et al.
Publicado: (2016)